A blood-based prognostic biomarker in IBD
暂无分享,去创建一个
Kenneth G. C. Smith | M. Parkes | T. Ahmad | James C. Lee | A. Hart | P. Lyons | E. McKinney | N. Lewis | D. Biasci | N. Noor | D. Pombal | Monica Hou
[1] Correction: A blood-based prognostic biomarker in IBD , 2019, Gut.
[2] Kenneth G. C. Smith,et al. PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial , 2018, BMJ Open.
[3] G. Gibson. Going to the negative: genomics for optimized medical prescription , 2018, Nature Reviews Genetics.
[4] Virginia G Kaklamani,et al. Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer , 2018, The New England journal of medicine.
[5] Evan W. Newell,et al. Epigenomic‐Guided Mass Cytometry Profiling Reveals Disease‐Specific Features of Exhausted CD8 T Cells , 2018, Immunity.
[6] J. Colombel,et al. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease , 2018, Alimentary pharmacology & therapeutics.
[7] R. Atreya,et al. IBD in 2017: Development of therapy for and prediction of IBD — getting personal , 2018, Nature Reviews Gastroenterology & Hepatology.
[8] Tariq Ahmad,et al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn's disease , 2017, Nature Genetics.
[9] L. V. van't Veer,et al. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer. , 2016, The New England journal of medicine.
[10] J. Mclaughlin,et al. What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance , 2016, Journal of Crohn's & colitis.
[11] Paul A. Lyons,et al. T cell exhaustion, costimulation and clinical outcome in autoimmunity and infection , 2015, Nature.
[12] H. Zou,et al. An Efficient Algorithm for Computing the HHSVM and Its Generalizations , 2013 .
[13] Miles Parkes,et al. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. , 2011, The Journal of clinical investigation.
[14] E. Wherry. T cell exhaustion , 2011, Nature Immunology.
[15] Joseph P. Costantino,et al. Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20 , 2011, Breast Cancer Research and Treatment.
[16] P. Rutgeerts,et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. , 2010, The New England journal of medicine.
[17] Alvis Brazma,et al. A CD8 T cell transcription signature predicts prognosis in autoimmune disease , 2010, Nature Medicine.
[18] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[19] G. D'Haens. Top-down therapy for IBD: rationale and requisite evidence , 2010, Nature Reviews Gastroenterology &Hepatology.
[20] Hao Helen Zhang,et al. ON THE ADAPTIVE ELASTIC-NET WITH A DIVERGING NUMBER OF PARAMETERS. , 2009, Annals of statistics.
[21] M. Vatn,et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) , 2009, Scandinavian journal of gastroenterology.
[22] M. Vos,et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2008, The Lancet.
[23] M. Vatn,et al. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[24] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[25] K. Van Steen,et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour , 2007, Gut.
[26] Kenneth G. C. Smith,et al. Microarray analysis of human leucocyte subsets: the advantages of positive selection and rapid purification , 2007, BMC Genomics.
[27] S. Dorn. Predictors of Crohn's disease. , 2006, Gastroenterology.
[28] P. Seksik,et al. Predictors of Crohn's disease. , 2006, Gastroenterology.
[29] Richard Simon,et al. Bias in error estimation when using cross-validation for model selection , 2006, BMC Bioinformatics.
[30] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[31] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[32] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[33] Benjamin M. Bolstad,et al. affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..
[34] Martin Vingron,et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression , 2002, ISMB.
[35] W. Tremaine,et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.
[36] Tim F. Rayner,et al. Gene expression profiling of CD 8 + T cells predicts prognosis in patients with Crohn disease and ulcerative colitis , 2018 .
[37] G. Lichtenstein. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour , 2008 .
[38] T. Eberlein. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer , 2006 .
[39] Andrew E. Jaffe,et al. Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .
[40] R. Gentleman,et al. Bioinformatics Applications Note Arrayqualitymetrics—a Bioconductor Package for Quality Assessment of Microarray Data , 2022 .